U.S. Food & Drug: Administration 10903 New Hampshire Avenue Silver Spring, MD 20993
U.S. Food & Drug: Administration 10903 New Hampshire Avenue Silver Spring, MD 20993
U.S. Food & Drug: Administration 10903 New Hampshire Avenue Silver Spring, MD 20993
Re: K220311
Trade/Device Name: Cardiovascular Angiography System
Regulation Number: 21 CFR 892.1650
Regulation Name: Image-Intensified Fluoroscopic X-Ray System
Regulatory Class: Class II
Product Code: OWB, JAA, OXO
Dated: January 27, 2022
Received: February 2, 2022
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced
above and have determined the device is substantially equivalent (for the indications for use stated in the
enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the
enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance
with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a
premarket approval application (PMA). You may, therefore, market the device, subject to the general
controls provisions of the Act. Although this letter refers to your product as a device, please be aware that
some cleared products may instead be combination products. The 510(k) Premarket Notification Database
located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination
product submissions. The general controls provisions of the Act include requirements for annual registration,
listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We
remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be
subject to additional controls. Existing major regulations affecting your device can be found in the Code of
Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements
concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA
has made a determination that your device complies with other requirements of the Act or any Federal
statutes and regulations administered by other Federal agencies. You must comply with all the Act's
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part
801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803) for
devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see
https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-
combination-products); good manufacturing practice requirements as set forth in the quality systems (QS)
regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for
combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-
542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part
807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part
803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-
mdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including
information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-
devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn
(https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the
Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See
the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-
assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE
by email ([email protected]) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Digitally signed by
Laurel M. Burk -S
Date: 2022.05.03
13:44:32 -04'00'
Laurel Burk
Assistant Director
Diagnostic X-ray Systems Team
DHT 8B: Division of Radiological Imaging Devices and
Electronic Products
OHT8: Office of Radiological Health
Office of Product Evaluation and Quality
Center for Devices and Radiological Health
Enclosure
DEPARTMENT OF HEALTH AND HUMAN SERVICES Form Approved: OMB No. 0910-0120
Food and Drug Administration Expiration Date: 06/30/2023
Indications for Use See PRA Statement below.
Device Name
Cardiovascular Angiography System
Clinical applications may include (but not limited to) interventional cardiovascular procedures, Neurovascular
procedures, pacemaker implantable and high end investigations.
This system should be handled by persons who have been briefed in its professional handling and who have familiarized
themselves with the product by means of instructions for use. Intended use also means following the user manual and
observing the conditions for inspection and maintenance.
Prescription Use (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 801 Subpart C)
2. Proposed Device:
Device (trade) name: Cardiovascular Angiography System
Model Name: Proxima FDX, Altima FDX Adv
Digiscan FDX-V8043, Digiscan FDX-V8030, Digiscan FDX-V8020
Digiscan FDX-V6543, Digiscan FDX-V6530, Digiscan FDX-V6520
Digiscan FDX-V4043, Digiscan FDX-V4030, Digiscan FDX-V4020
Digiscan FDX-V2743, Digiscan FDX-V2730, Digiscan FDX-V2720
Classification Name : Image-Intensified Fluoroscopic X-Ray System
Classification Panel: Radiology
Regulation Number : 21 CFR 892.1650
Device Class: Class II
Product Code: Primary Code : OWB
Subsequent Code : JAA and OXO for 1Digiscan FDX-VXXYY
3. Predicate Device:
Device (trade) name: Allura Xper FD Series and Allura Xper OR Table series
510(K) Number : K162859
Clearance Date : December 2, 2016
Classification Name: Image-Intensified Fluoroscopic X-Ray System,
Classification Panel: Radiology
Regulation Number : 21 CFR 892.1650
Device Class : Class II
Product Code: Primary Code : OWB
Subsequent Code : JAA
1
Where XX may be 80/65/40/27 and YY may be 43/30/20
5. Device description:
The Cardiovascular Angiography system is designed to perform fluoroscopic & digital
radiographic studies and are used in interventional examinations. This system covers
the complete range of angiographic applications, cardiac angiography, neuro-
angiography, general angiography, surgery and surgical angiography, multipurpose
angiography, rotational angiography and digital radiographic/ fluoroscopic procedures.
The following components are configured to create the Cardiovascular Angiography
system:
1. Floor mounted C-arm (Altima FDX Adv) or Ceiling Mounted C-Arm (Proxima
FDX) or Mobile C-Arm (2Digiscan FDX-VXXYY), X-ray tube assembly and Solid
State X-Ray image detector
2. Patient Table
3. Ceiling suspended display(s)
2
Where XX may be 80/65/40/27 and YY may be 43/30/20
Proxima FDX
X-Ray Generator Allengers XGEN-100CV
Altima FDX Adv
Proxima FDX
Altima FDX Adv
X-Ray Generator Allengers Digiscan FDX-V8043 XGEN-80CV
Digiscan FDX-V8030
Digiscan FDX-V8020
Digiscan FDX-V6543
X-Ray Generator Allengers Digiscan FDX-V6530 XGEN-65CV
Digiscan FDX-V6520
Digiscan FDX-V4043
X-Ray Generator Allengers Digiscan FDX-V4030 XGEN-40CV
Digiscan FDX-V4020
Digiscan FDX-V2743
X-Ray Generator Allengers Digiscan FDX-V2730 XGEN-27CV
Digiscan FDX-V2720
Digiscan FDX-V2743
A-145, RAD-99,
X-Ray Tube Varex Imaging Digiscan FDX-V2730
RAD-99B, RAD-15
Digiscan FDX-V2720
Proxima FDX
Altima FDX Adv
Solid State X-
Digiscan FDX-V8020
Ray Image Varex Imaging Paxscan 2020 DXV
Digiscan FDX-V6520
Detectors
Digiscan FDX-V4020
Digiscan FDX-V2720
Proxima FDX
Altima FDX Adv
Solid State X-
Digiscan FDX-V8030
Ray Image Varex Imaging Paxscan 3030 DXV
Digiscan FDX-V6530
Detectors
Digiscan FDX-V4030
Digiscan FDX-V2730
Proxima FDX
Altima FDX Adv
Solid State X-
Digiscan FDX-V8043
Ray Image Varex Imaging Paxscan 4343DXV
Digiscan FDX-V6543
Detectors
Digiscan FDX-V4043
Digiscan FDX-V2743
Proxima FDX
Altima FDX Adv
Solid State X-
IRAY Digiscan FDX-V8020
Ray Image Mercu 0909F
Technology Digiscan FDX-V6520
Detectors
Digiscan FDX-V4020
Digiscan FDX-V2720
Proxima FDX
Altima FDX Adv Pixium 2121S-AU
Solid State X-
Digiscan FDX-V8020 Pixium Surgical
Ray Image Thales Group
Digiscan FDX-V6520 2121S-A
Detectors
Digiscan FDX-V4020
Digiscan FDX-V2720
Proxima FDX
Altima FDX Adv
Solid State X- Pixium 3030S-AU
Digiscan FDX-V8030
Ray Image Thales Group Pixium Surgical
Digiscan FDX-V6530
Detectors 3030S-A
Digiscan FDX-V4030
Digiscan FDX-V2730
Solid State X- Proxima FDX
CFP 2222
Ray Image MX Imaging Altima FDX Adv
Detectors Digiscan FDX-V8020
Clinical applications may include (but not limited to) interventional cardiovascular
procedures, Neurovascular procedures, pacemaker implantable and high end
investigations.
This system should be handled by persons who have been briefed in its professional
handling and who have familiarized themselves with the product by means of
instructions for use. Intended use also means following the user manual and observing
the conditions for inspection and maintenance.
8. Software Feature
Synergy FP FDX & Synergy FDX-CR imaging software is a Digital Imaging System
(DIS) provides useful functions to manage X-Ray images obtained from
Cardiovascular Angiography System.
The software feature set and functions is essentially the same as the device, with the
system complying with DICOM 3.0 specifications .Refer to section 9 Image processing
and storage of the table 3 for a list of top level functions
9. Substantial Equivalence:
The Cardiovascular Angiography system are substantially equivalent to the
commercially available Allura Xper FD series and Allura Xper OR Table series
(K162859) & Ziehm Vision RFD (K203428). Functional and specification differences
are identifying in the following table.
3
Where XX may be 80/65/40/27 and YY may be 43/30/20
In conclusion, the identified risk of electrical hazards was mitigated and it is the
Allengers opinion that Cardiovascular Angiography system appears to be as safe and
effective as predicate & reference device.
Reference Standard
Recognition Product
Title of standard Number and Development
Number Area
date organization
Medical Electrical Equipment ±
Part 1: General requirements for 60601-1:2012,
19-4 General IEC
basic safety and essential ed. 3.1
performance
Medical electrical equipment ± Part
1-2: General requirements for basic
60601-1-2
safety and essential performanc e ±
19-8 General Edition 4.0 IEC
Collat eral Standard:
2014-02
Electromagnetic Compatibility ±
Requirements and tests
Medical Electrical Equipment Part
1-3: General Requirements for
60601-1-3
Basic Safety and Essential
12-269 Radiology Edition 2.1 IEC
Performance. -Collateral Standard:
2013-04
Radiation Protection in Diagnostic
X-Ray Equipment.
Particular requirements for the 60601-2-43
12-308 Radiology safety of X-Ray equipment for Edition 2.1, IEC
interventional procedures 2017